There are many Aurora A inhibitors (for review see [99]); a particularly interesting example is ENMD-2076b—it was shown that triple-negative breast cancer cells with mutated p53 and increased expression were more sensitive to the cytotoxic effects of ENMD-2076 than cells with reduced p53 expression [100]. The gene discussed is TP53; the disease is triple-negative breast carcinoma.